NCT04050410View on ClinicalTrials.gov

Autonomic Determinants of POTS - Pilot1

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Postural Tachycardia Syndrome

Interventions

DRUG

Moxonidine

active drug given as 1 dose

DRUG

Placebo

placebo pill given as 1 dose

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER